CardioClusters use three types of cells to reduce scar tissue and improve function by integrating into and persisting within damaged heart tissue. Cell therapy for cardiac regeneration, while promising, has been hampered by issues with long-term survival of the transplanted cells. Now, a technique that combines three different types of cells in a 3D cluster could improve its efficacy in reducing scar tissue and improving cardiac function after a heart attack. Continue reading →

ROCKVILLE, Md., Sept. 8, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration announced today that a multi-institutional team of scientists from eight American research centers published a research paper on new therapeutic approaches for COVID-19 in which they propose that Thymosin beta 4 (T4), because of its ability to induce fibrinolysis, among other activities, may be useful in treating patients with the COVID-19 virus. Continue reading →

24.5 Million Covered Lives Now Eligible for Biologic Advanced Wound Care Treatment Through Centene Corporation SUWANEE, GA, Sept. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin, musculoskeletal tissue and vascular structures, announced today that Centene Corporation, the largest Medicare and Medicaid Administrator in the U.S., has included BIOVANCE® in its list of reimbursed skin substitutes for advanced wound healing for the more than 24.5 million lives it covers. Continue reading →

Zimmer Biomet For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999632 Key Market Trends: Cardiology is Expected to hold its Highest Market Share in the Application Segment In the application segment of the market, cardiology is believed to have the largest market size and is expected to witness a CAGR of 16.0% during the forecast period. Recent years have observed promising applications of polymeric biomaterials in cardiac repair and regeneration. Organ failure is also one among the major health problems, globally recognized Continue reading →